COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 2875: Articles 28741-28750  | Next

Modeling and Dynamics in Epidemiology, COVID19 withLockdown and Isolation Effect : Application to Moroccan Case
YAFIA, R.
10.1101/2020.04.29.20084871 — Posted: 2020-05-02
How and when to end the COVID-19 lockdown: an optimisation approach
Rawson, T., Brewer, T., Veltcheva, D., Huntingford, C., Bonsall, M. B.
10.1101/2020.04.29.20084517 — Posted: 2020-05-02
A surprising formula for the spread of Covid-19 under aggressive management
Cherednik, I.
10.1101/2020.04.29.20084483 — Posted: 2020-05-02
A possible role of immunopathogenesis in COVID-19 progression
Anft, M., Paniskaki, K., Blazquez-Navarro, A., Doevelaar, A. A. N., Seibert, F., Hoelzer, B., Skrzypczyk, S., Kohut, E., Kurek, J., Zapka, J., Wehler, P., Kaliszczyk, S., Bajda, S., Thieme, C., Roch, T., Konik, M. J., Brenner, T., Tempfer, C., Watzl, C., Dolff, S., Dittmer, U., Westhoff, T., Witzke, O., Stervbo, U., Babel, N.
10.1101/2020.04.28.20083089 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Identification of Three Endotypes in Pediatric Acute Respiratory Distress Syndrome by Nasal Transcriptomic Profiling
Williams, J. G., Joshi, R., Jones, R., Yunger, T., Stoneman, E., Varisco, B. M.
10.1101/2020.04.28.20083451 — Posted: 2020-05-02
Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients
Hachim, A., Kavian, N., Cohen, C. A., Chin, A. W., Chu, D. K., Mok, C. K. P., Tsang, O. T., Yeung, Y. C., Perera, R. A., Poon, L. L., Peiris, M. J., Valkenburg, S. A.
10.1101/2020.04.30.20085670 — Posted: 2020-05-02 Discussion: Onsite
Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses
Mutnal, M. B., Arroliga, A. C., Walker, K., Mohammad, A. A., Brigmon, M. M., Beaver, R. M., Midturi, J. K., Rao, A.
10.1101/2020.04.30.20086116 — Posted: 2020-05-02 Discussion: Offsite
Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
Norman, M., Gilboa, T., Ogata, A. F., Maley, A. M., Cohen, L., Cai, Y., Zhang, J., Feldman, J. E., Hauser, B. M., Caradonna, T. M., Chen, B., Schmidt, A. G., Alter, G., Charles, R. C., Ryan, E. T., Walt, D. R.
10.1101/2020.04.28.20083691 — Posted: 2020-05-02
Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers
Zhang, Z., Xiao, T., Wang, Y., Yuan, J., Ye, H., Wei, L., Wang, H., Liao, X., Qian, S., Wang, Z., Liu, L.
10.1101/2020.04.28.20083139 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Radon, K., Saathoff, E., Pritsch, M., Guggenbuehl Noller, J. M., Kroidl, I., Olbrich, L., Thiel, V., Diefenbach, M., Riess, F., Forster, F., Theis, F. J., Wieser, A., Hoelscher, M., KoCo19 collaboration group
10.1101/2020.04.28.20082743 — Posted: 2020-05-02 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).